We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On August 3, 2009, the U.S. Food and Drug Administration (FDA) announced a collaborative agreement with the European Medicines Agency (EMEA) for a Good Clinical Practices (GCP) Initiative
